Market Overview:
The global electrical stimulation devices (ESDs) market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the ESDs market can be attributed to the increasing prevalence of chronic diseases, technological advancements in ESDs devices, and rising geriatric population. Based on type, the spinal cord stimulation (SCS) devices segment is expected to account for the largest share of the global ESDs market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030 due to increasing demand for SCS devices for pain management applications. Based on application, the pain management segment is expected to account for the largest share of the global ESDs market in 2018.
 Industry Outlook.svg)
Product Definition:
Electrical stimulation devices (ESDs) are tools used to deliver electrical current to the body. This current can be used for a variety of purposes, including stimulating muscles, nerves, or the heart. ESDs can also be used to treat conditions like pain or inflammation.
Spinal Cord Stimulation (SCS) Devices:
Spinal cord stimulation devices are used to treat severe chronic pain by delivering mild electrical current to the spinal nerves. The treatment is usually done in outpatient settings and patients may return to their normal activities immediately after the procedure. SCS has been approved by the U.
Deep Brain Stimulation (DBS) Devices:
Deep brain stimulation (DBS) is a surgical procedure used to treat various movement and psychiatric disorders such as Parkinson's disease, dystonia, or epilepsy. DBS devices are also known as neurostimulators or electrical stimulators. The surgery involves placing a battery-powered device that sends regular and mild pulses of electricity into the brain to relieve symptoms of the target disorder.
Application Insights:
The pain management segment dominated the global application segment in 2017. The high prevalence of chronic pain disorders and growing awareness about various treatment options are some of the factors contributing to this growth. For instance, according to a study published in NCBI, around 20% of adults experience chronic neck or back pain every year and around 50 million adult Americans have suffered from chronic lower limb (leg) pain during the past month. Therefore, such trends are expected to increase the adoption rate for electrical stimulation devices for treating various types of chronic pains over the forecast period.
Electrical stimulation is used as an alternative therapy for Parkinson¢â‚¬â„¢s disease due to its ability to stimulate dopamine production which results in improving motor symptoms associated with PD such as rigidity, bradykinesia (slowness), postural instability and depression.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and high adoption rate for innovative technologies. The region is expected to maintain its dominance throughout the forecast period due to increasing cases of chronic pain, neurological disorders, and movement disorders. Moreover, rising prevalence of diabetes is also anticipated to fuel demand for electrical stimulation devices in this region.
Asia Pacific market was valued at USD X million in 2017 and is expected to grow at a lucrative rate over the forecast period owing with rapid economic development coupled with growing awareness about various treatment options available for various diseases & conditions especially pertaining Electrical Stimulation Devices (ESDs). Increasing incidence rates of Parkinson’s disease are also positively impacting growth across this region.
Growth Factors:
- Increasing geriatric population: The global geriatric population is expected to grow at a CAGR of 6.5% from 2016 to 2020, owing to the increase in life expectancy and the growth in the number of people aged 65 years and above. This will result in an increase in demand for ESDs, as they are used for treating various age-related conditions.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as arthritis, diabetes, and cardiovascular disorders is increasing globally due to changing lifestyles and environmental factors. This is leading to an increase in demand for ESDs as they are used for treating various chronic conditions.
- Technological advancements: The development of new technologies has led to the introduction of novel ESD devices that are more effective and user-friendly than traditional devices. This is resulting in an increase in adoption rates of these devices, thereby driving market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Electrical Stimulation Devices (ESDs) Market Research Report
By Type
Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices, Gastric Electric Stimulation (GES) Devices, Transcutaneous electrical nerve stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices, Others
By Application
Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management (Stomach, Intestine, Pancreas, Digestion, Blood Pressure, Nausea, Vomiting, Gastroparesis, etc.), Incontinence Management (Fecal Incontinence, Urinary Incontinence, Urinary Retention), Others
By Companies
Boston Scientific, Abbott, Medtronic, Cyberonics, DJO Global, Nevro, NeuroMetrix, Cogentix Medical, Zynex, Boston Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
204
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Electrical Stimulation Devices (ESDs) Market Report Segments:
The global Electrical Stimulation Devices (ESDs) market is segmented on the basis of:
Types
Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices, Gastric Electric Stimulation (GES) Devices, Transcutaneous electrical nerve stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management (Stomach, Intestine, Pancreas, Digestion, Blood Pressure, Nausea, Vomiting, Gastroparesis, etc.), Incontinence Management (Fecal Incontinence, Urinary Incontinence, Urinary Retention), Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Abbott
- Medtronic
- Cyberonics
- DJO Global
- Nevro
- NeuroMetrix
- Cogentix Medical
- Zynex
- Boston Scientific
 Market Overview.svg)
Highlights of The Electrical Stimulation Devices (ESDs) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Spinal Cord Stimulation (SCS) Devices
- Deep Brain Stimulation (DBS) Devices
- Vagus Nerve Stimulation (VNS) Devices
- Sacral Nerve Stimulation (SNS) Devices
- Gastric Electric Stimulation (GES) Devices
- Transcutaneous electrical nerve stimulation (TENS) Devices
- Neuromuscular Electrical Stimulation (NMES/EMS) Devices
- Others
- By Application:
- Pain Management
- Neurological and Movement Disorder Management
- Musculoskeletal Disorder Management
- Metabolism & GIT Management (Stomach, Intestine, Pancreas, Digestion, Blood Pressure, Nausea, Vomiting, Gastroparesis, etc.)
- Incontinence Management (Fecal Incontinence, Urinary Incontinence, Urinary Retention)
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Electrical Stimulation Devices (ESDs) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Electrical stimulation devices are medical devices that use electrical currents to treat a variety of conditions. ESDs can be used to treat pain, depression, anxiety, and other mental health issues.
Some of the major companies in the electrical stimulation devices (esds) market are Boston Scientific, Abbott, Medtronic, Cyberonics, DJO Global, Nevro, NeuroMetrix, Cogentix Medical, Zynex, Boston Scientific.
The electrical stimulation devices (esds) market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Electrical Stimulation Devices (ESDs) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Electrical Stimulation Devices (ESDs) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Electrical Stimulation Devices (ESDs) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Electrical Stimulation Devices (ESDs) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Electrical Stimulation Devices (ESDs) Market Size & Forecast, 2020-2028
4.5.1 Electrical Stimulation Devices (ESDs) Market Size and Y-o-Y Growth
4.5.2 Electrical Stimulation Devices (ESDs) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Spinal Cord Stimulation (SCS) Devices
5.2.2 Deep Brain Stimulation (DBS) Devices
5.2.3 Vagus Nerve Stimulation (VNS) Devices
5.2.4 Sacral Nerve Stimulation (SNS) Devices
5.2.5 Gastric Electric Stimulation (GES) Devices
5.2.6 Transcutaneous electrical nerve stimulation (TENS) Devices
5.2.7 Neuromuscular Electrical Stimulation (NMES/EMS) Devices
5.2.8 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pain Management
6.2.2 Neurological and Movement Disorder Management
6.2.3 Musculoskeletal Disorder Management
6.2.4 Metabolism & GIT Management (Stomach
6.2.5 Intestine
6.2.6 Pancreas
6.2.7 Digestion
6.2.8 Blood Pressure
6.2.9 Nausea
6.2.10 Vomiting
6.2.11 Gastroparesis
6.2.12 etc.)
6.2.13 Incontinence Management (Fecal Incontinence
6.2.14 Urinary Incontinence
6.2.15 Urinary Retention)
6.2.16 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Electrical Stimulation Devices (ESDs) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Electrical Stimulation Devices (ESDs) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Spinal Cord Stimulation (SCS) Devices
9.6.2 Deep Brain Stimulation (DBS) Devices
9.6.3 Vagus Nerve Stimulation (VNS) Devices
9.6.4 Sacral Nerve Stimulation (SNS) Devices
9.6.5 Gastric Electric Stimulation (GES) Devices
9.6.6 Transcutaneous electrical nerve stimulation (TENS) Devices
9.6.7 Neuromuscular Electrical Stimulation (NMES/EMS) Devices
9.6.8 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pain Management
9.10.2 Neurological and Movement Disorder Management
9.10.3 Musculoskeletal Disorder Management
9.10.4 Metabolism & GIT Management (Stomach
9.10.5 Intestine
9.10.6 Pancreas
9.10.7 Digestion
9.10.8 Blood Pressure
9.10.9 Nausea
9.10.10 Vomiting
9.10.11 Gastroparesis
9.10.12 etc.)
9.10.13 Incontinence Management (Fecal Incontinence
9.10.14 Urinary Incontinence
9.10.15 Urinary Retention)
9.10.16 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Spinal Cord Stimulation (SCS) Devices
10.6.2 Deep Brain Stimulation (DBS) Devices
10.6.3 Vagus Nerve Stimulation (VNS) Devices
10.6.4 Sacral Nerve Stimulation (SNS) Devices
10.6.5 Gastric Electric Stimulation (GES) Devices
10.6.6 Transcutaneous electrical nerve stimulation (TENS) Devices
10.6.7 Neuromuscular Electrical Stimulation (NMES/EMS) Devices
10.6.8 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pain Management
10.10.2 Neurological and Movement Disorder Management
10.10.3 Musculoskeletal Disorder Management
10.10.4 Metabolism & GIT Management (Stomach
10.10.5 Intestine
10.10.6 Pancreas
10.10.7 Digestion
10.10.8 Blood Pressure
10.10.9 Nausea
10.10.10 Vomiting
10.10.11 Gastroparesis
10.10.12 etc.)
10.10.13 Incontinence Management (Fecal Incontinence
10.10.14 Urinary Incontinence
10.10.15 Urinary Retention)
10.10.16 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Spinal Cord Stimulation (SCS) Devices
11.6.2 Deep Brain Stimulation (DBS) Devices
11.6.3 Vagus Nerve Stimulation (VNS) Devices
11.6.4 Sacral Nerve Stimulation (SNS) Devices
11.6.5 Gastric Electric Stimulation (GES) Devices
11.6.6 Transcutaneous electrical nerve stimulation (TENS) Devices
11.6.7 Neuromuscular Electrical Stimulation (NMES/EMS) Devices
11.6.8 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pain Management
11.10.2 Neurological and Movement Disorder Management
11.10.3 Musculoskeletal Disorder Management
11.10.4 Metabolism & GIT Management (Stomach
11.10.5 Intestine
11.10.6 Pancreas
11.10.7 Digestion
11.10.8 Blood Pressure
11.10.9 Nausea
11.10.10 Vomiting
11.10.11 Gastroparesis
11.10.12 etc.)
11.10.13 Incontinence Management (Fecal Incontinence
11.10.14 Urinary Incontinence
11.10.15 Urinary Retention)
11.10.16 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Spinal Cord Stimulation (SCS) Devices
12.6.2 Deep Brain Stimulation (DBS) Devices
12.6.3 Vagus Nerve Stimulation (VNS) Devices
12.6.4 Sacral Nerve Stimulation (SNS) Devices
12.6.5 Gastric Electric Stimulation (GES) Devices
12.6.6 Transcutaneous electrical nerve stimulation (TENS) Devices
12.6.7 Neuromuscular Electrical Stimulation (NMES/EMS) Devices
12.6.8 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pain Management
12.10.2 Neurological and Movement Disorder Management
12.10.3 Musculoskeletal Disorder Management
12.10.4 Metabolism & GIT Management (Stomach
12.10.5 Intestine
12.10.6 Pancreas
12.10.7 Digestion
12.10.8 Blood Pressure
12.10.9 Nausea
12.10.10 Vomiting
12.10.11 Gastroparesis
12.10.12 etc.)
12.10.13 Incontinence Management (Fecal Incontinence
12.10.14 Urinary Incontinence
12.10.15 Urinary Retention)
12.10.16 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Spinal Cord Stimulation (SCS) Devices
13.6.2 Deep Brain Stimulation (DBS) Devices
13.6.3 Vagus Nerve Stimulation (VNS) Devices
13.6.4 Sacral Nerve Stimulation (SNS) Devices
13.6.5 Gastric Electric Stimulation (GES) Devices
13.6.6 Transcutaneous electrical nerve stimulation (TENS) Devices
13.6.7 Neuromuscular Electrical Stimulation (NMES/EMS) Devices
13.6.8 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pain Management
13.10.2 Neurological and Movement Disorder Management
13.10.3 Musculoskeletal Disorder Management
13.10.4 Metabolism & GIT Management (Stomach
13.10.5 Intestine
13.10.6 Pancreas
13.10.7 Digestion
13.10.8 Blood Pressure
13.10.9 Nausea
13.10.10 Vomiting
13.10.11 Gastroparesis
13.10.12 etc.)
13.10.13 Incontinence Management (Fecal Incontinence
13.10.14 Urinary Incontinence
13.10.15 Urinary Retention)
13.10.16 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Electrical Stimulation Devices (ESDs) Market: Competitive Dashboard
14.2 Global Electrical Stimulation Devices (ESDs) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Abbott
14.3.3 Medtronic
14.3.4 Cyberonics
14.3.5 DJO Global
14.3.6 Nevro
14.3.7 NeuroMetrix
14.3.8 Cogentix Medical
14.3.9 Zynex
14.3.10 Boston Scientific
